EUVIMEDEUVIMED entdecken
Evaluationsstudie

Label-free impedimetric immunosensor for the detection of Fibulin-2 as a novel biomarker for the diagnosis of hypertrophic cardiomyopathy in human saliva

Ayman Ali Saeed, Ayman Maher Ibrahim, Mohamed Mahmoud Eissa, Naglaa Mohammed Nooredeen, Mohammed Nooredeen Abbas, Marie Hangouёt, Joan Bausells, Abdelhamid Errachid, Nadia Zine

Biosensors and Bioelectronics · 2025

DOI: 10.1016/j.bios.2025.117939 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Biosensors and Bioelectronics, 2025. Verfasst von Ayman Ali Saeed und 8 weiteren Autor:innen. Beteiligte Einrichtung: Applied Organic Chemistry Department, Chemical Industries Research Institute, National Research Centre (NRC), Dokki, Giza, 12622, Egypt. Hauptthemen laut MEDLINE: Saliva, Biosensing Techniques, Cardiomyopathy, Hypertrophic, Calcium-Binding Proteins. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Academy of Scientific Research and Technology, Ministère de l'Enseignement supérieur et de la Recherche, Ministère de l'Europe et des Affaires Étrangères.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A novel label-free impedimetric immunosensor was developed for the detection of the recently reported cardiac biomarker, Fibulin-2 (FBLN2) in both PBS and human saliva, for the diagnosis of cardiac conditions such as Hypertrophic Cardiomyopathy (HCM). The immunosensor device was based on four gold working electrodes (WEs) biofunctionalized with the corresponding antibody, anti-Fibulin-2 (anti-FBLN2), through amide bond formation between the carboxylic groups of 16-mercaptohexanoic acid (MHDA), assembled as a monolayer on the gold surface, and the amino groups of the antibody. Surface modification and biofunctionalization of the WEs were characterized by contact angle measurement (CAM), Fourier-transform infrared spectroscopy (FTIR), Cyclic Voltammetry (CV) and Electrochemical Impedance Spectroscopy (EIS) while the FBLN2 detection was confirmed by EIS analyses. The immunosensor demonstrated high sensitivity with good linearity in the range of 5-25 pg/mL (R2 = 0.97) with a limit of detection (LOD) of 1.64 pg/mL. Practical application was further validated by detecting FBLN2 in human saliva using the same concentration range and the standard addition method. The results confirm the immunosensor's capability for selective detection of FBLN2 in a saliva matrix and its potential as a rapid, cost-effective diagnostic tool.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SalivaBiosensing TechniquesCardiomyopathy, HypertrophicCalcium-Binding ProteinsHumansBiomarkersDielectric SpectroscopyLimit of DetectionImmunoassayAntibodies, ImmobilizedGold

Stichwörter der Autor:innen

Cardiac biomarkerElectrochemical impedance spectroscopyFibulin-2Human salivaHypertrophic cardiomyopathyImpedimetric immunosensor

Substanzen

BiomarkersCalcium-Binding ProteinsAntibodies, ImmobilizedGold

Autor:innen und Institutionen

  • Applied Organic Chemistry Department, Chemical Industries Research Institute, National Research Centre (NRC), Dokki, Giza, 12622, Egypt.
  • Zoology Department, Faculty of Science, Cairo University, Giza, 12613, Egypt; Institute of Cardiovascular Physiology, University Göttingen, Göttingen, 37073, Germany.
  • Polymers and Pigments Department, Chemical Industries Research Institute, National Research Centre (NRC), Dokki, Giza, 12622, Egypt.
  • Universite Claude Bernard Lyon 1, ISA, UMR 5280, CNRS, 5 rue de la Doua, 69100, Villeurbanne, France.
  • Instituto de Microelectrónica de Barcelona (IMB-CNM-CSIC), Campus Universitat Autònoma de Barcelona (UAB), Barcelona, 08193, Spain.
  • Universite Claude Bernard Lyon 1, ISA, UMR 5280, CNRS, 5 rue de la Doua, 69100, Villeurbanne, France. Electronic address: nadia.zine@univ-lyon1.fr.

Förderung

  • Academy of Scientific Research and Technology
  • Ministère de l'Enseignement supérieur et de la Recherche
  • Ministère de l'Europe et des Affaires Étrangères

Zitieren

APA

Saeed, A. A., Ibrahim, A. M., Eissa, M. M., Nooredeen, N. M., Abbas, M. N., Hangouёt, M., Bausells, J., Errachid, A., & Zine, N. (2025). Label-free impedimetric immunosensor for the detection of Fibulin-2 as a novel biomarker for the diagnosis of hypertrophic cardiomyopathy in human saliva. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2025.117939

Vancouver

Saeed AA, Ibrahim AM, Eissa MM, Nooredeen NM, Abbas MN, Hangouёt M, et al. Label-free impedimetric immunosensor for the detection of Fibulin-2 as a novel biomarker for the diagnosis of hypertrophic cardiomyopathy in human saliva. Biosensors and Bioelectronics. 2025. doi:10.1016/j.bios.2025.117939

BibTeX
@article{Saeed2025,
  author = {Saeed, Ayman Ali and Ibrahim, Ayman Maher and Eissa, Mohamed Mahmoud and Nooredeen, Naglaa Mohammed and Abbas, Mohammed Nooredeen and Hangouёt, Marie and Bausells, Joan and Errachid, Abdelhamid and Zine, Nadia},
  title = {Label-free impedimetric immunosensor for the detection of Fibulin-2 as a novel biomarker for the diagnosis of hypertrophic cardiomyopathy in human saliva},
  journal = {Biosensors and Bioelectronics},
  year = {2025},
  doi = {10.1016/j.bios.2025.117939}
}
Kostenlos starten →